Abstract
Purpose
To investigate the relation between a diabetes risk reduction diet (DRRD) and ovarian cancer.
Methods
We used data from a multicentric case-control study conducted in Italy, including 1031 incident ovarian cancer cases and 2411 controls admitted to hospital centres for acute non-malignant disease. Subjects’ diet prior to hospital admission was collected using a validated food frequency questionnaire. Adherence to the DRRD was measured using a score based on 8 dietary components, giving higher scores for greater intakes of cereal fiber, coffee, fruit, nuts, higher polyunsaturated to saturated fatty acids ratio, lower glycemic index of diet, and lower intakes of red/processed meat, and sweetened beverages/and fruit juices. Higher scores indicated greater adherence to the DRRD. Multiple logistic regression models were fitted to calculate the odds ratios (OR) of ovarian cancer and the corresponding 95% confidence intervals (CI) for approximate quartiles of the DRRD score.
Results
The DRRD score was inversely related to ovarian cancer, with an OR of 0.76 (95%CI: 0.60–0.95) for the highest versus the lowest quartile of the score (p for trend = 0.022). The exclusion of women with diabetes did not change the results (OR = 0.75, 95%CI: 0.59–0.95). Inverse associations were observed in strata of age, education, parity, menopausal status, and family history of ovarian/breast cancer.
Conclusion
Higher adherence to a diet aimed at reducing the risk of diabetes was inversely associated with ovarian cancer. Further evidence from prospective investigations will be useful to support our findings.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Women with diabetes mellitus are at increased risk of ovarian cancer [1], but the mechanism of such association is unclear. Hyperglycemia and hyperinsulinemia can influence ovarian cancer risk through the modulation of the insulin-like growth factor (IGF) axis [2]. Hyperinsulinemia downregulates IGF binding proteins (IGFBP) concentrations and increases free IGF-1 which promotes cellular proliferation and inhibits apoptosis [3]. In addition, inflammatory mediators and cytokines, such as interleukin-1, interleukin-6, and tumor necrosis factor, produced by the hyperglycemic state, act as growth factors by increasing angiogenesis, facilitating a tumour-favourable microenvironment, and potentially causing immune hyperactivation and tumour cell growth [4].
Diets high in glycemic index (GI) and glycemic load (GL) have been associated to type 2 diabetes risk [5, 6] and to unfavorable changes in IGFBP-3 [7]. While GI and GL were associated with an increased risk of ovarian cancer [8,9,10], the role of several other dietary factors on the disease is still poorly defined [11]. A dietary pattern approach allows to take into account the biologic interactions between foods and nutrients.
Rhee et al. [12] proposed a type 2 diabetes prevention diet (diabetes risk reduction diet, DRRD) characterized by high intakes of cereal fiber, polyunsaturated fatty acids, coffee, and nuts, and low intakes of carbohydrates, red and processed meat, sugar-sweetened beverages, and trans fatty acids. In 2020, fruit was added among the protective components and fruit juices were added among the unfavorable components of the sugar-sweetened beverages [13]. In a large cohort study from USA, the DRRD was associated with a lower risk of death from all causes, cardiovascular disease, and cancer [14]. The DRRD was also inversely associated with the risk of breast [13, 15, 16], hepatocellular [17], pancreatic [18, 19], and endometrial cancers [20]. To our knowledge, however, no study evaluated the relation between the DRRD and ovarian cancer.
In the present study, we investigated the relation between adherence to the DRRD and ovarian cancer using data from a multicentric Italian study.
Methods
Data Source and Study Population
Data were derived from a multicentric case-control study of ovarian cancer conducted between January 1992 and September 1999 in four Italian areas: the greater Milan area and the provinces of Pordenone, Padua, and Gorizia in northern Italy; the province of Latina in central Italy; and the urban area of Naples in southern Italy [21]. The study included 1031 cases (median age 56 years, range 18 to 79) and 2411 controls (median age 57 years, range 17 to 79).
Cases were women with a histologically confirmed incident invasive epithelial ovarian cancer admitted to the major university and general hospitals of the study areas. Controls were women admitted to the same network of hospitals as cases for a wide spectrum of acute non-malignant illnesses: traumas (26%); non-traumatic orthopedic disorders (28%); acute surgical conditions (15%); and miscellaneous other illnesses including eye, nose, ear, throat, or dental disorders (31%). Controls were excluded if they had undergone bilateral ovariectomy or if hospitalized for hormone-related, gynecological conditions, digestive tract diseases, or any clinical condition leading to long-term dietary modifications. Less than 4% of women approached refused to take part in the study and the participation rate did not vary across catchment areas or hospitals. The Ethics Committees of the Hospital “Niguarda Ca’ Granda”, Milan, and of the National Cancer Institute “Centro di Riferimento Oncologico, IRCCS”, Aviano, provided the study approval (respectively, 1125/194 and IRB-15).
Centrally trained personnel interviewed cases and controls during their hospital stay, using the same structured questionnaire and coding manual. Interviewers could not be blinded to case/control status. The questionnaire included information on sociodemographic and anthropometric features, lifestyle behaviors, personal clinical information, family (first-degree relatives) history of cancer, menstrual and reproductive factors, and use of oral contraceptives (OC) and hormone replacement therapy (HRT).
The dietary habits during the 2 years preceding cancer diagnosis (for cases) or hospitalization admission (for controls) were investigated through a valid [22] and reproducible [23, 24] food frequency questionnaire (FFQ) that included 78 items. Subjects were asked to indicate their average weekly frequency of consumption of single foods or food groups. Occasional intakes, i.e., less than once a week but at least once per month, were arbitrarily coded as 0.5 per week. To compute total energy and nutrient intake, an Italian food composition database was used [25]. Dietary GI values were derived mainly from international GI Table [26]; Italian sources were used for a few local recipes [27].
Derivation of the DRRD score
A DRRD score was computed according to the last approach proposed in the literature [13], without trans fats, which were not included in the Italian food composition tables. The score was based on 5 dietary components favorably associated with diabetes risk, i.e., cereal fiber, coffee, fruit, ratio of polyunsaturated to saturated fatty acids, and nuts, and 3 dietary components unfavorably associated with diabetes, i.e., high dietary GI, red and processed meat, and sweetened beverages and fruit juices. We assigned scores between 1 (intake consistent with the highest diabetes risk) and 5 (intake consistent with the lowest diabetes risk) according to quintiles of consumption (derived from controls). The consumption of sugar-sweetened beverages and fruit juices was relatively uncommon in our population (61.2% of subjects reported no consumption), and thus we assigned a score of 5 to non-drinkers, a score of 3 to drinkers of ≤ 1.5 drinks per week (i.e., the median value among drinking controls), and a score of 1 to drinkers of more than 1.5 drinks per week. The consumption of nuts was reported in an open-end question of the FFQ; women declaring nut consumption were given a score of 2; otherwise, a score of 1 was assigned. Supplementary Table S1 shows the scoring of the dietary components included in the DRRD score. The individual overall DRRD score was computed as the sum of points obtained for each dietary component. Thus, the theoretical range of the final score was 8–37, with higher scores indicating greater adherence to the DRRD.
Data analysis
We categorized the DRRD score into approximate quartiles with cutoffs derived from controls (< 22, 22–23, 24–25, and ≥ 26). Logistic regression models were fitted to calculate the odds ratios (OR) of ovarian cancer and the corresponding 95% confidence intervals (CI) for approximate quartiles of the DRRD score, using the lowest quartile as the reference category. The OR for a one-point increment in the score was also estimated. Models included terms of age (< 45, 45–54, 55–64, ≥ 65 years), center, year of interview, years of education (< 7, 7–11, ≥ 12), total energy intake (in quintiles), history of diabetes, menopausal status, parity (0–1, ≥ 2 children), use of OC, and family history of ovarian or breast cancer. The 7 women with missing menopausal status were all aged less than 49 years. Thus, they were considered as pre-menopausal.
In sensitivity analyses we repeated the main analysis excluding women with diabetes, excluding one component at a time from the overall DRRD score, and adding further adjustment for alcohol intake. We carried out stratified analyses by age, education, parity, menopausal status, and family history of ovarian/breast cancer. We tested for heterogeneity across strata using the likelihood ratio test comparing models including and not including interaction terms between the DRRD score and the stratification variable.
All statistical analyses were conducted with SAS statistical software version 9.4 (SAS Institute, Inc., Cary, NC, USA).
Results
Table 1 shows the distribution of 1031 ovarian cancer cases and 2411 controls according to age and selected covariates. Cases had higher education and energy intake, and reported more frequently a family history of ovarian or breast cancer. The distribution of total energy intake according to the DRRD score is reported in Supplementary Table S2.
Table 2 gives the OR and the corresponding 95% CI of ovarian cancer by approximate quartiles of the DRRD score, in the overall population and in non-diabetic women. High adherence to the DRRD was inversely related to ovarian cancer, with an OR for the fourth versus the first quartile of 0.76 (95% CI: 0.60–0.95; p for trend = 0.022). The corresponding OR after excluding women with diabetes was 0.75 (95% CI: 0.59–0.95). Consistent results were obtained also adding further adjustment for alcohol intake (OR = 0.75, 95% CI: 0.60–0.95).
When we excluded from the calculation each component of the score at a time, we found similar results in terms of direction and magnitude of the association; however, some of the confidence intervals became larger (Supplementary Table S3).
In subgroups analyses, no heterogeneity was found in strata of age, education, parity, menopausal status, and family history of ovarian/breast cancer (Table 3).
Discussion
In this multicentric Italian study, high adherence to the DRRD was inversely associated with ovarian cancer. After allowance for several potential confounders, including measures of endogenous estrogen exposure, use of OC, family history of ovarian/breast cancer, and total energy intake, women with the highest DRRD adherence scores had a 24% reduced risk of ovarian cancer, as compared to those with the lowest scores.
No conclusive evidence on the role of diet in ovarian cancer risk is available [11], with selected dietary factors showing limited effects on ovarian cancer occurrence [28]. According to a recent umbrella review [29], ovarian cancer risk was inversely related to black tea and calcium, and positively related to skim/low-fat milk and lactose though with a weak level of evidence.
As concerns the components of the DRRD with a protective role on diabetes, a meta-analysis including only cohort studies found no significant association between the intake of caffeine or different types of coffee and the risk of ovarian cancer [30]. Another investigation based on case-control studies documented an inverse association with decaffeinated coffee consumption [31]. A Swedish cohort study found no association between dietary phytoestrogens and the risk of ovarian cancer; however, the Swedish diet is likely to contain low amounts of phytoestrogens, from nuts, berries, beans/soy, and whole-grain bread, making it difficult to detect an association [32]. Few cohort studies reported non-significant inverse associations with fruit intake [33,34,35,36], while in other studies fruit played a favourable role against epithelial ovarian cancer [37, 38]. In a meta-analysis of 19 observational studies, fiber intake was inversely associated with ovarian cancer risk [39]. Dietary fiber may influence the disease by reducing the bioavailability of steroid hormones through changes in gut bacterial microflora, lowering availability and serum levels of estrogens, and increasing protection of lignans and other phytoestrogens [40]. In addition, dietary fiber may lower GI and GL and improve insulin sensitivity, favorably regulating IGF-1 [41]. IGF-1 stimulates cellular proliferation and inhibits apoptosis, and therefore may promote ovarian carcinogenesis [3].
Diets high in GI and GL could lead to chronic hyperinsulinemia and insulin suppresses IGFBP concentrations [7, 42]; in an Italian case-control study, ovarian cancer was inversely related to IGFBP, in particular to IGFBP-3 [43]. IGFBP-3 affect the half-life and bioavailability of IGF and may also exert IGF-1-independent effects under certain conditions [44]. At least 9 studies provided information on GI and GL and ovarian cancer risk with mixed results [8,9,10, 45,46,47,48,49,50]. A meta-analysis, based on 8 studies, gave a summary relative risk (RR) of 1.22 for high versus low GL [51]. In a previous analysis on data from the present case-control study, GI and GL were both associated with an increased ovarian cancer risk of approximately 70% [10]. Likewise, in a Canadian cohort study, high dietary GL was related to a 72% increased risk of ovarian cancer after a mean follow-up of 16 years [45]. In another study from Australia, a modest association between GL and the risk of ovarian cancer risk was found in women with overweight and/or obesity [8]. However, a cohort study from the USA found a reduced risk of ovarian cancer with higher GL [46]. Another American cohort study also observed lower risk of ovarian cancer associated with higher GI and GL [9]. The remaining 4 studies did not observe significant associations [47,48,49,50].
A meta-analysis of 8 prospective studies published up to 2011 found no appreciable association with red and processed meat [52]. Another meta-analysis published in 2011 including also case-control studies found that women with the highest intake of processed meat had a 20% increased risk of the disease and only a marginal association with red meat intake [53]. A meta-analysis of 21 observational studies indicated that consumption of total dietary fats and trans fats increased the risk of ovarian cancer [54]. A more recent meta-analysis found that also high intakes of saturated and partially monounsaturated fats, as well as cholesterol, were associated with an increased risk of ovarian cancer [55]. However, the evidence linking dietary fats with ovarian cancer risk is inconsistent across populations [56] possibly also due to the source of dietary fat consumed. Monounsaturated fatty acids from olive oil showed a modest inverse association with ovarian cancer risk in Greece, a country with the world highest consumption of olive oil [57]. High dietary fats may stimulate the secretion of estrogen [58], which can exert tumor promoting activity via mitogenic effects on ERα- positive [59, 60] or negative tumor cells [61, 62]. No associations emerged with consumption of sugar-sweetened beverages [49, 63, 64].
A pro-inflammatory diet was associated to ovarian cancer risk in studies conducted in African American [65], Australian [66], and Italian [67] women. Along this line, the original DRRD scoring system attributes higher scores to anti-inflammatory components, such as fruit and cereal fiber, and lower scores to components known to have pro-inflammatory properties, such as meat and trans fats.
Potential study limitations include the inability to account for trans fatty acids in the DRRD score since the they are not available in the Italian food composition tables. In addition, despite the window of dietary recall up to two years prior to cancer diagnosis, we could not exclude the pre-clinical symptoms modified the diet. Among the strengths, the catchment areas and the interview setting were similar for cases and controls and the participation rate was almost complete. In addition, the exclusion of women admitted for hormone-related or gynecological conditions, or any clinical condition leading to long-term modifications of diet reduced selection bias. Other strengths are the large sample size, the use of a valid [22] and reproducible [23, 24] FFQ, and the ability to control for several potential confounders.
In conclusion, this study suggests that high adherence to a diet able to reduce the risk of diabetes may also be inversely associated with ovarian cancer. Further evidence from prospective investigations is needed to support our findings.
Data Availability
The dataset generated and analysed during the current study are available from the corresponding author on reasonable request.
Change history
14 February 2024
A Correction to this paper has been published: https://doi.org/10.1007/s10552-024-01863-7
References
Wang L, Zhong L, Xu B, Chen M, Huang H (2020) Diabetes mellitus and the risk of ovarian cancer: a systematic review and meta-analysis of cohort and case-control studies. BMJ Open 10:e040137
Kellenberger LD, Bruin JE, Greenaway J et al (2010) The role of dysregulated glucose metabolism in epithelial ovarian cancer. J Oncol 2010:514310
Yu H, Rohan T (2000) Role of the insulin-like growth factor family in cancer development and progression. Jnci-J Natl Cancer I 92:1472–1489
Chang SC, Yang WV (2016) Hyperglycemia, tumorigenesis, and chronic inflammation. Crit Rev Oncol Hematol 108:146–153
Livesey G, Taylor R, Livesey HF et al (2019) Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: Assessment of Causal Relations. Nutrients. 11
Livesey G, Taylor R, Livesey HF et al (2019) Dietary glycemic index and load and the risk of type 2 diabetes: a systematic review and updated Meta-analyses of prospective cohort studies. Nutrients. 11.
Brand-Miller JC, Liu V, Petocz P, Baxter RC (2005) The glycemic index of foods influences postprandial insulin-like growth factor-binding protein responses in lean young subjects. Am J Clin Nutr 82:350–354
Nagle CM, Kolahdooz F, Ibiebele TI et al (2011) Carbohydrate intake, glycemic load, glycemic index, and risk of ovarian cancer. Ann Oncol 22:1332–1338
Mongiovi JM, Freudenheim JL, Moysich KB, McCann SE (2021) Glycemic Index, Glycemic load, and risk of Ovarian Cancer in the prostate, lung, colorectal and ovarian (PLCO) cohort. J Nutr 151:1597–1608
Augustin LSA, Polesel J, Bosetti C et al (2003) Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in Italy. Ann Oncol 14:78–84
Crane TE, Khulpateea BR, Alberts DS, Basen-Engquist K, Thomson CA (2014) Dietary intake and ovarian Cancer risk: a systematic review. Cancer Epidem Biomar 23:255–273
Rhee JJ, Mattei J, Hughes MD, Hu FB, Willett WC (2015) Dietary diabetes risk reduction score, race and ethnicity, and risk of type 2 diabetes in women. Diabetes Care 38:596–603
Kang JH, Peng C, Rhee JJ et al (2020) Prospective study of a diabetes risk reduction diet and the risk of breast cancer. Am J Clin Nutr 112:1492–1503
Wang CR, Hu TY, Hao FB et al (2022) Type 2 Diabetes-Prevention Diet and all-cause and cause-specific mortality: a prospective study. Am J Epidemiol 191:472–486
Mousavi SE, Bagheri A, Benisi-Kohansal S, Azadbakht L, Esmaillzadeh A (2022) Consumption of “Diabetes Risk Reduction Diet” and odds of breast Cancer among women in a Middle Eastern Country. Front Nutr. 9
Turati F, Bravi F, Rossi M et al (2022) Diabetes risk reduction diet and the risk of breast cancer. Eur J Cancer Prev 31:339–345
Luo X, Sui J, Yang WS et al (2019) Type 2 diabetes Prevention Diet and Hepatocellular Carcinoma Risk in US Men and Women. Am J Gastroenterol 114:1870–1877
Turati F, Rossi M, Mattioli V, Bravi F, Negri E, La Vecchia C (2022) Diabetes risk reduction diet and the risk of pancreatic cancer. Eur J Nutr 61:309–316
Huang Y, Liu F, Chen AM et al (2021) Type 2 diabetes prevention diet and the risk of pancreatic cancer: a large prospective multicenter study. Clin Nutr 40:5595–5604
Esposito G, Bravi F, Serraino D, Parazzini F, Crispo A, Augustin LSA, Negri E, La Vecchia C, Turati F (2021) Diabetes risk reduction diet and endometrial cancer risk. Nutrients 13(8):2630
Bosetti C, Negri E, Franceschi S et al (2001) Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer 93:911–915
Decarli A, Franceschi S, Ferraroni M et al (1996) Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol 6:110–118
Franceschi S, Negri E, Salvini S et al (1993) Reproducibility of an Italian food frequency questionnaire for cancer studies: results for specific food items. Eur J Cancer 29A:2298–2305
Franceschi S, Barbone F, Negri E et al (1995) Reproducibility of an italian food frequency questionnaire for cancer studies. Results for specific nutrients. Ann Epidemiol 5:69–75
Gnagnarella P, Parpinel M, Salvini S (2004) The update of the italian food composition database. J Food Comp Anal 17:509–522
Foster-Powell K, Miller JB (1995) International tables of glycemic index. Am J Clin Nutr 62:871S–90S
Brighenti F, Casiraghi MC (1992) Influenza dei processi di trasformazione sulla risposta glicemica ad alimenti amidacei. Giornale Italiano di Nutrizione Clinica e Preventiva 1:79–87
Khodavandi A, Alizadeh F, Razis AFA (2021) Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis. Eur J Nutr 60:1707–1736
Sun H, Gong TT, Xia Y et al (2021) Diet and ovarian cancer risk: an umbrella review of systematic reviews and meta-analyses of cohort studies. Clin Nutr 40:1682–1690
Salari-Moghaddam A, Milajerdi A, Surkan PJ, Larijani B, Esmaillzadeh A (2019) Caffeine, type of Coffee, and risk of ovarian Cancer: a dose-response Meta-analysis of prospective studies. J Clin Endocrinol Metab 104:5349–5359
Shafiei F, Salari-Moghaddam A, Milajerdi A, Larijani B, Esmaillzadeh A (2019) Coffee and caffeine intake and risk of ovarian cancer: a systematic review and meta-analysis. Int J Gynecol Cancer 29:579–584
Hedelin M, Lof M, Andersson TM, Adlercreutz H, Weiderpass E (2011) Dietary phytoestrogens and the risk of ovarian cancer in the women’s lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev 20:308–317
Koushik A, Hunter DJ, Spiegelman D et al (2005) Fruits and vegetables and ovarian cancer risk in a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 14:2160–2167
Larsson SC, Holmberg L, Wolk A (2004) Fruit and vegetable consumption in relation to ovarian cancer incidence: the swedish mammography cohort. Br J Cancer 90:2167–2170
Mommers M, Schouten LJ, Goldbohm RA, van den Brandt PA (2005) Consumption of vegetables and fruits and risk of ovarian carcinoma. Cancer 104(7):1512–1519
Schulz M, Lahmann PH, Boeing H et al (2005) Fruit and vegetable consumption and risk of epithelial ovarian cancer: the european prospective investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 14:2531–2535
Tang L, Lee AH, Su D, Binns CW (2014) Fruit and vegetable consumption associated with reduced risk of epithelial ovarian cancer in southern chinese women. Gynecol Oncol 132:241–247
Zhang M, Yang ZY, Binns CW, Lee AH (2002) Diet and ovarian cancer risk: a case-control study in China. Br J Cancer 86:712–717
Xu H, Ding Y, Xin X, Wang W, Zhang D (2018) Dietary fiber intake is associated with a reduced risk of ovarian cancer: a dose-response meta-analysis. Nutr Res 57:1–11
Rock CL, Flatt SW, Thomson CA et al (2004) Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. J Clin Oncol 22:2379–2387
Slavin JL (2005) Dietary fiber and body weight. Nutrition 21:411–418
Augustin LSA, Kendall CWC, Jenkins DJA et al (2015) Glycemic index, glycemic load and glycemic response: an International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC). Nutr Metab Cardiovasc Dis 25:795–815
Dal Maso L, Augustin LSA, Franceschi S et al (2004) Association between components of the insulin-like growth factor system and epithelial ovarian cancer risk. Oncology-Basel 67:225–230
LeRoith D, Roberts CT Jr (2003) The insulin-like growth factor system and cancer. Cancer Lett 195:127–137
Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE (2007) Glycaemic index, glycaemic load and ovarian cancer risk: a prospective cohort study. Public Health Nutr 10:1076–1081
George SM, Mayne ST, Leitzmann MF et al (2009) Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol 169:462–472
Hu J, La Vecchia C, Augustin LS et al (2013) Glycemic index, glycemic load and cancer risk. Ann Oncol 24:245–251
Sieri S, Agnoli C, Pala V et al (2017) Dietary glycemic index, glycemic load, and cancer risk: results from the EPIC-Italy study. Sci Rep-Uk. 7
King MG, Olson SH, Paddock L et al (2013) Sugary food and beverage consumption and epithelial ovarian cancer risk: a population-based case-control study. BMC Cancer 13:94
Qin B, Moorman PG, Alberg AJ et al (2016) Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in african-american women. Brit J Nutr 115:694–702
Turati F, Galeone C, Augustin LSA, La Vecchia C (2019) Glycemic Index, Glycemic load and Cancer risk: an updated Meta-analysis. Nutrients. 11.
Wallin A, Orsini N, Wolk A (2011) Red and processed meat consumption and risk of ovarian cancer: a dose-response meta-analysis of prospective studies. Br J Cancer 104:1196–1201
Kolahdooz F, van der Pols JC, Bain CJ et al (2010) Meat, fish, and ovarian cancer risk: results from 2 australian case-control studies, a systematic review, and meta-analysis. Am J Clin Nutr 91:1752–1763
Qiu W, Lu H, Qi Y, Wang X (2016) Dietary fat intake and ovarian cancer risk: a meta-analysis of epidemiological studies. Oncotarget 7:37390–37406
Sadeghi A, Shab-Bidar S, Parohan M, Djafarian K (2019) Dietary Fat Intake and Risk of Ovarian Cancer: a systematic review and dose-response Meta-analysis of Observational Studies. Nutr Cancer 71:939–953
Rice MS, Poole EM, Willett WC, Tworoger SS (2020) Adult dietary fat intake and ovarian cancer risk. Int J Cancer 146:2756–2772
Tzonou A, Hsieh CC, Polychronopoulou A et al (1993) Diet and ovarian-Cancer - a case-control study in Greece. Int J Cancer 55:411–414
Zahid M, Beseler CL, Hall JB, LeVan T, Cavalieri EL, Rogan EG (2014) Unbalanced estrogen metabolism in ovarian cancer. Int J Cancer 134:2414–2423
Gallo D, De Stefano I, Prisco MG, Scambia G, Ferrandina G (2012) Estrogen receptor Beta in Cancer: an attractive target for Therapy. Curr Pharm Design 18:2734–2757
Ribeiro JR, Freiman RN (2014) Estrogen signaling crosstalk: implications for endocrine resistance in ovarian cancer. J Steroid Biochem 143:160–173
Lukanova A, Kaaks R (2005) Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 14:98–107
Ciucci A, Zannoni GF, Buttarelli M et al (2016) Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers. Oncotarget 7:8155–8171
Arthur RS, Kirsh VA, Mossavar-Rahmani Y, Xue X, Rohan TE (2021) Sugar-containing beverages and their association with risk of breast, endometrial, ovarian and colorectal cancers among canadian women. Cancer Epidemiol 70:101855
Leung AC, Cook LS, Swenerton K et al (2016) Tea, coffee, and caffeinated beverage consumption and risk of epithelial ovarian cancers. Cancer Epidemiol 45:119–125
Peres LC, Bandera EV, Qin B et al (2017) Dietary inflammatory index and risk of epithelial ovarian cancer in african american women. Int J Cancer 140:535–543
Nagle CM, Ibiebele T, Shivappa N et al (2019) The association between the inflammatory potential of diet and risk of developing, and survival following, a diagnosis of ovarian cancer. Eur J Nutr 58:1747–1756
Shivappa N, Hebert JR, Rosato V et al (2016) Dietary inflammatory index and ovarian cancer risk in a large italian case-control study. Cancer Causes Control 27:897–906
Funding
Open access funding provided by Università degli Studi di Milano within the CRUI-CARE Agreement.
Author information
Authors and Affiliations
Contributions
Conceptualization: FP, EN, CLV; Formal analysis and data curation: GE, FT; Methodology: GE, FT; Investigation, DS, EN, CLV; Writing-original draft preparation: GE; Writing-review and editing: FT, FP, LSAA, DS, EN; all authors have read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Informed consent was obtained from all subjects involved in the study according to the recommendations of the Board of Ethics of each participating center.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: The affiliation of Livia S. A. Augustin has been revised.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Esposito, G., Turati, F., Parazzini, F. et al. Diabetes risk reduction diet and ovarian cancer risk: an Italian case-control study. Cancer Causes Control 34, 769–776 (2023). https://doi.org/10.1007/s10552-023-01722-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-023-01722-x